Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
agilon health set to report earnings as profitability questions loom By Investing.com
5+ hour, 53+ min ago (202+ words) Updated Aug 05, 2026 14:56 agilon health Inc. is set to release second-quarter results after the market closes Wednesday, a closely watched report for the value-based care provider as investors scrutinize whether revenue growth can translate into sustained profitability. The mixed analyst outlook…...
Dropbox stock hits 52-week high at $34.64 By Investing.com
10+ hour, 54+ min ago (124+ words) Investing.com UK Dropbox stock hits 52-week high at $34.64 Published Jan 01, 0001 00:00 Updated Aug 05, 2026 15:40 In other recent news, Dropbox Inc. reported impressive financial results for the first quarter of 2026, surpassing both earnings and revenue expectations. The company posted earnings per share…...
Fiserv earnings on deck: New CEO faces test on turnaround path By Investing.com
8+ hour, 9+ min ago (316+ words) Updated Aug 05, 2026 18:48 Fiserv Inc. reports second-quarter results before the market opens Thursday, with investors scrutinizing whether new leadership can deliver on promises of a turnaround after months of executive departures and a stock price collapse that has erased more than…...
Freedom Broker upgrades Snap stock rating to buy on strong Q2 results By Investing.com
19+ hour, 22+ min ago (237+ words) Freedom Broker upgrades Snap stock rating to buy on strong Q2 results Investing.com UK Freedom Broker upgrades Snap stock rating to buy on strong Q2 results Published Jan 01, 0001 00:00 Updated Aug 04, 2026 21:38 Investing.com - Freedom Broker upgraded Snap Inc (NYSE:SNAP) to buy…...
All eyes on NCR Atleos earnings ahead of Brink’s acquisition By Investing.com
21+ hour, 32+ min ago (448+ words) Updated Aug 04, 2026 19:18 NCR Atleos Corp will report second-quarter earnings before the market opens Wednesday, delivering what could be its final results as a standalone company ahead of its pending acquisition by The Brink’s Company. Analysts expect earnings per share of…...
Canaccord reiterates Hold on Snap stock after strong Q2 results By Investing.com
1+ day, 5+ hour ago (369+ words) Investing.com UK Canaccord reiterates Hold on Snap stock after strong Q2 results Published Jan 01, 0001 00:00 Updated Aug 04, 2026 12:38 Investing.com - Canaccord Genuity reiterated a Hold rating and $6.00 price target on Snap Inc (NYSE:SNAP) following the company’s second-quarter results that exceeded expectations…...
American Financial earnings on deck: Can specialty edge last? By Investing.com
1+ day, 1+ min ago (214+ words) Updated Aug 04, 2026 19:56 The $11.9 billion company operates primarily in property and casualty insurance, focusing on specialized commercial products for businesses. Analysts rate the stock a Buy with a mean price target of $147.17, implying 3.7% upside from the current price of $141.92. Wells Fargo…...
Mercury General earnings beat by $1.12, revenue topped estimates By Investing.com
21+ hour, 5+ min ago (106+ words) Updated Aug 05, 2026 01:18 Investing.com - Mercury General (NYSE: MCY) reported second quarter EPS of $3.52, $1.12 better than the analyst estimate of $2.40. Revenue for the quarter came in at $1.56B versus the consensus estimate of $1.5B. Mercury General’s stock price closed at $106.60. It is up…...
Descartes launches AI trade compliance tool for duty savings By Investing.com
1+ day, 6+ hour ago (189+ words) Updated Aug 04, 2026 11:54 LONDON and ATLANTA - Descartes Systems Group (NASDAQ:DSGX) (TSX:DSG) announced today the launch of its Free Trade Intelligence solution, an artificial intelligence-enabled platform designed to help manufacturers, importers and exporters qualify goods for preferential tariff treatment. The…...
Xencor faces earnings test after revenue miss rocks biotech By Investing.com
1+ day, 6+ hour ago (301+ words) Updated Aug 04, 2026 20:12 Xencor Inc, a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, reports second-quarter results Wednesday as investors look for signs of revenue recovery following a brutal first-quarter miss. The sequential revenue comparison…...